Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials

Understanding Patient Engagement Trends in Atopic Dermatitis Clinical Research

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06174493

Enrollment

500

Registered

2023-12-18

Start date

2025-01-31

Completion date

2027-01-31

Last updated

2024-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Keywords

atopic dermatitis

Brief summary

Clinical trials, specifically focused on atopic dermatitis, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation. The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.

Interventions

None listed

Study design

Observational model

CASE_CROSSOVER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Ability to understand and the willingness to sign a written informed consent document * Participant must be 18 years of age or older * Confirmed diagnosis of atopic dermatitis

Exclusion criteria

* Enrolled in another research study * Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study * Inability to provide written informed consent

Design outcomes

Primary

Measure	Time frame
Number of atopic dermatitis patients who decide to enroll in a clinical research	3 months
Rate of atopic dermatitis patients who remain in clinical trial to trial completion	12 months

Countries

United States

Contacts

Primary ContactMichael B Gill

bask@withpower.com415-900-4227

Outcome results